TY  - JOUR
PY  - 2024//
TI  - Assessing the labeling information on drugs associated with suicide risk: systematic review
JO  - JMIR public health and surveillance
A1  - Jeon, Soo Min
A1  - Lim, HyunJoo
A1  - Cheon, Hyo-Bin
A1  - Ryu, Juhee
A1  - Kwon, Jin-Won
SP  - e49755
EP  - e49755
VL  - 10
IS  - 
N2  - BACKGROUND: Drug-induced suicide (DIS) is a severe adverse drug reaction (ADR). Although clinical trials have provided evidence on DIS, limited investigations have been performed on rare ADRs, such as suicide. <br><br>OBJECTIVE: We aimed to systematically review case reports on DIS to provide evidence-based drug information. <br><br>METHODS: We searched PubMed to obtain case reports regarding DIS published until July 2021. Cases resulting from drugs that are no longer used or are nonapproved, substance use, and suicidal intentions were excluded. The quality of each case report was assessed using the CASE (Case Reports) checklist. We extracted data regarding demographics, medication history, suicide symptoms, and symptom improvement and evaluated the causality of DIS using the Naranjo score. Furthermore, to identify the potential suicidal risk of the unknown drugs, we compared the results of the causality assessment with those of the approved drug labels. <br><br>RESULTS: In 83 articles, we identified 152 cases involving 61 drugs. Antidepressants were reported as the most frequent causative drugs of DIS followed by immunostimulants. The causality assessment revealed 61 cases having possible, 89 cases having probable, and 2 cases having definite relationships with DIS. For approximately 85% of suspected drugs, the risk of suicidal ADRs was indicated on the approved label; however, the approved labels for 9 drugs, including lumacaftor/ivacaftor, doxycycline, clozapine, dextromethorphan, adalimumab, infliximab, piroxicam, paclitaxel, and formoterol, did not provide information about these risks. <br><br>CONCLUSIONS: We found several case reports involving drugs without suicide risk information on the drug label. Our findings might provide valuable insights into drugs that may cause suicidal ADRs.<p />  <p>Language: en</p>
LA  - en
SN  - 2369-2960
UR  - http://dx.doi.org/10.2196/49755
ID  - ref1
ER  -